Dimensional Fund Advisors LP Has $4.34 Million Stock Holdings in Semler Scientific, Inc. (NASDAQ:SMLR)

Dimensional Fund Advisors LP raised its stake in Semler Scientific, Inc. (NASDAQ:SMLR) by 18.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 126,177 shares of the company’s stock after buying an additional 19,552 shares during the period. Dimensional Fund Advisors LP’s holdings in Semler Scientific were worth $4,341,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of SMLR. CWM LLC increased its holdings in Semler Scientific by 486.3% in the 2nd quarter. CWM LLC now owns 897 shares of the company’s stock worth $31,000 after purchasing an additional 744 shares in the last quarter. Rhumbline Advisers grew its holdings in shares of Semler Scientific by 27.1% during the second quarter. Rhumbline Advisers now owns 6,197 shares of the company’s stock worth $213,000 after purchasing an additional 1,320 shares during the last quarter. Quest Partners LLC acquired a new position in shares of Semler Scientific in the second quarter valued at approximately $59,000. Bank of New York Mellon Corp raised its holdings in Semler Scientific by 10.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 20,618 shares of the company’s stock valued at $709,000 after buying an additional 1,940 shares during the last quarter. Finally, Meeder Asset Management Inc. acquired a new stake in Semler Scientific during the 2nd quarter worth approximately $67,000. Institutional investors own 49.37% of the company’s stock.

Semler Scientific Price Performance

SMLR opened at $26.44 on Thursday. The company’s 50 day moving average price is $26.06 and its two-hundred day moving average price is $28.61. The firm has a market capitalization of $186.83 million, a price-to-earnings ratio of 9.48 and a beta of 0.96. Semler Scientific, Inc. has a fifty-two week low of $20.88 and a fifty-two week high of $53.38.

Semler Scientific (NASDAQ:SMLR) last posted its quarterly earnings data on Monday, August 5th. The company reported $0.64 EPS for the quarter, topping analysts’ consensus estimates of $0.56 by $0.08. Semler Scientific had a return on equity of 21.17% and a net margin of 25.62%. The company had revenue of $14.47 million for the quarter.

Insider Transactions at Semler Scientific

In other news, CEO Douglas Murphy-Chutorian sold 10,000 shares of the stock in a transaction dated Thursday, August 29th. The shares were sold at an average price of $28.35, for a total transaction of $283,500.00. Following the transaction, the chief executive officer now owns 60,220 shares of the company’s stock, valued at $1,707,237. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 13.00% of the company’s stock.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.